Pro Treatment Review- Allumera Photodynamic Therapy Truth In Aging The treatment consists of a topical light absorbing cream (Allumera) that's activated by exposing the skin to a source of light determined by your healthcare professional. This treatment is aimed at restoring a youthful and even-toned appearance ...
Biofrontera and Desitin sign marketing and distribution agreement for AmeluzR ... Reuters The product is applied in the relatively novel photodynamic therapy (PDT). PDT of actinic keratosis lesions with Ameluz R leads to very high efficacy and excellent cosmetic results, without the side-effects and discomfort of a long-term treatment.
BIOFRONTERA AG : Biofrontera's Ameluz® as of today available in all German ... 4-traders (press release) Due to the excellent cosmetic results many physicians choose PDT particularly for the treatment of expanded skin damage. With its superior results of clinical trials, the agencies have allowed for Ameluz® a broader spectrum of use within actinic ...
Investing 101: Insiders Love These Stocks with Improving Profit Margins Kapitall Blog (blog) DUSA Pharmaceuticals Inc. (DUSA, Earnings, Analysts, Financials): Develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada, and Korea. Gross profit margins increased ...
Radiance Skin Therapy & Laser Center, Now Offering New Photodynamic Cosmetic ... PR Web (press release) Radiance Skin Therapy & Laser Center is thrilled to be offering Allumera as a new photodynamic cosmetic treatment that produces dynamic results for timeless skin and offers a new way for women & men to look their best at any age. Radiance Skin Therapy...
Dusa Pharmaceuticals (DUSA) Downgraded by Zacks Investment Research to "Neutral" LocalizedUSA DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company that is developing and marketing Levulan photodynamic therapy (Levulan PDT), and other products for common skin conditions. Its marketed products include Levulan Kerastick ...
Ceno Technologies, Roswell sign deal on compound development Buffalo Business First Ceno Technologies Inc. and Roswell Park Cancer Institute have signed a licensing deal to develop compounds for photodynamic therapy. The deal gives Ceno the right to develop a compound called HPPH using photodynamic therapy (PDT) for skin surface ...
